Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bacterial Infections and Mycoses

  Free Subscription

Articles published in
J Med Chem
    May 2024
  1. HE Y, Ruan S, Liang G, Hao J, et al
    A Nonbactericidal Anionic Antimicrobial Peptide Provides Prophylactic and Therapeutic Efficacies against Bacterial Infections in Mice by Immunomodulatory-Antithrombotic Duality.
    J Med Chem. 2024;67:7487-7503.
    >> Share

    April 2024
  2. NI T, Hao Y, Ding Z, Chi X, et al
    Discovery of a Novel Potent Tetrazole Antifungal Candidate with High Selectivity and Broad Spectrum.
    J Med Chem. 2024;67:6238-6252.
    >> Share

    March 2024
  3. YANG W, Liu R, Li Z, Tu J, et al
    Discovery of New Tricyclic Oxime Sampangine Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcosis and Candidiasis.
    J Med Chem. 2024;67:4726-4738.
    >> Share

  4. MUSZALSKA-KOLOS I, Dwiecki PM
    Searching for Conjugates as New Structures for Antifungal Therapies.
    J Med Chem. 2024;67:4298-4321.
    >> Share

  5. FRANCO AR, Sadones O, Romerio A, Artusa V, et al
    Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies.
    J Med Chem. 2024 Mar 21. doi: 10.1021/acs.jmedchem.3c02215.
    >> Share

  6. XU T, Yan X, Kang A, Yang L, et al
    Development of Membrane-Targeting Fluorescent 2-Phenyl-1H-phenanthro[9,10-d]imidazole-Antimicrobial Peptide Mimic Conjugates against Methicillin-Resistant Staphylococcus aureus.
    J Med Chem. 2024 Mar 16. doi: 10.1021/acs.jmedchem.4c00436.
    >> Share

  7. HEIDTMANN CV, Fejer AR, Staerk K, Pedersen M, et al
    Hit-to-Lead Identification and Validation of a Triaromatic Pleuromutilin Antibiotic Candidate.
    J Med Chem. 2024;67:3692-3710.
    >> Share

  8. XIE F, Hao Y, Liu Y, Bao J, et al
    From Synergy to Monotherapy: Discovery of Novel 2,4,6-Trisubstituted Triazine Hydrazone Derivatives with Potent Antifungal Potency In Vitro and In Vivo.
    J Med Chem. 2024;67:4007-4025.
    >> Share

  9. HUANG Z, Gou X, Hang X, Shi T, et al
    Design, Synthesis, and Biological Evaluation of 5-(5-Iodo-2-isopropyl-4-methoxyphenoxy)pyrimidine-2,4-diamine (AF-353) Derivatives as Novel DHFR Inhibitors against Staphylococcus aureus.
    J Med Chem. 2024 Mar 11. doi: 10.1021/acs.jmedchem.3c02355.
    >> Share

    February 2024
  10. NEGI A, Perveen S, Gupta R, Singh PP, et al
    Unraveling Dilemmas and Lacunae in the Escalating Drug Resistance of Mycobacterium tuberculosis to Bedaquiline, Delamanid, and Pretomanid.
    J Med Chem. 2024 Feb 13. doi: 10.1021/acs.jmedchem.3c01892.
    >> Share

  11. CUI Y, Lanne A, Peng X, Browne E, et al
    Azetidines Kill Multidrug-Resistant Mycobacterium tuberculosis without Detectable Resistance by Blocking Mycolate Assembly.
    J Med Chem. 2024 Feb 8. doi: 10.1021/acs.jmedchem.3c01643.
    >> Share

  12. MADDIRALA AR, Pinkner JS, Tamadonfar K, Sanick D, et al
    Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections.
    J Med Chem. 2024 Feb 3. doi: 10.1021/acs.jmedchem.3c02128.
    >> Share

    January 2024
  13. GUO W, Yang Z, Wang K, Li W, et al
    Discovery of Unique Bis-Substituted Aromatic Amide Derivatives as Novel Highly Potent Antibiotics for Combating Methicillin-Resistant Staphylococcus aureus (MRSA).
    J Med Chem. 2024 Jan 30. doi: 10.1021/acs.jmedchem.3c02064.
    >> Share

  14. SOUKARIEH F, Mashabi A, Richardson W, Oton EV, et al
    Design, Synthesis, and Evaluation of New 1H-Benzo[d]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections.
    J Med Chem. 2024;67:1008-1023.
    >> Share

  15. YANG L, Hu X, Lu Y, Xu R, et al
    Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis.
    J Med Chem. 2024 Jan 17. doi: 10.1021/acs.jmedchem.3c01703.
    >> Share

  16. GALLARDO-MACIAS R, Russo R, Sherwood M, Jaskowski M, et al
    Small Molecule Benzothiophene with In Vivo Efficacy in a Mouse Model of Drug-Resistant Enterococcus faecium Infection.
    J Med Chem. 2024 Jan 15. doi: 10.1021/acs.jmedchem.3c01846.
    >> Share

  17. SANYAL K, Haldar J, Lindsley CW, Chibale K, et al
    Call for Papers: Fungal Pathogens - Life Cycle, Infection, Host Immunity and Drug Discovery.
    J Med Chem. 2024;67:1.
    >> Share

  18. CUN WY, Bate CE, Srikhanta YN, Hutton ML, et al
    Design, Synthesis, and Evaluation of Cephamycin-Based Antisporulation Agents targeting Clostridioides difficile.
    J Med Chem. 2024;67:450-466.
    >> Share

  19. LI C, Zhou Z, Wang W, Zhao Y, et al
    Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus.
    J Med Chem. 2024 Jan 3. doi: 10.1021/acs.jmedchem.3c01360.
    >> Share

  20. YUE C, Yuan Z, Xu G, Guan XN, et al
    Structure-Guided Design, Synthesis, and Antivirulence Assessment of Covalent Staphylococcus aureus Sortase A Inhibitors.
    J Med Chem. 2024 Jan 3. doi: 10.1021/acs.jmedchem.3c01615.
    >> Share

    December 2023
  21. RENARD S, Versluys S, Taillier T, Dubarry N, et al
    Optimization of the Antibacterial Spectrum and the Developability Profile of the Novel-Class Natural Product Corramycin.
    J Med Chem. 2023;66:16869-16887.
    >> Share

  22. OLIVEIRA NJC, Dos Santos Junior VS, Pierotte IC, Leocadio VAT, et al
    Discovery of Lead 2-Thiazolylhydrazones with Broad-Spectrum and Potent Antifungal Activity.
    J Med Chem. 2023;66:16628-16645.
    >> Share

  23. LIN H, Song L, Zhou S, Fan C, et al
    A Hybrid Antimicrobial Peptide Targeting Staphylococcus aureus with a Dual Function of Inhibiting Quorum Sensing Signaling and an Antibacterial Effect.
    J Med Chem. 2023 Dec 15. doi: 10.1021/acs.jmedchem.3c02027.
    >> Share

  24. LIN Y, Jung H, Bulman CA, Ng J, et al
    Discovery of New Broad-Spectrum Anti-Infectives for Eukaryotic Pathogens Using Bioorganometallic Chemistry.
    J Med Chem. 2023;66:15867-15882.
    >> Share

  25. MIAO ZY, Zhang XY, Yang MH, Huang YJ, et al
    3-Hydroxypyridin-4(1H)-one Derivatives as pqs Quorum Sensing Inhibitors Attenuate Virulence and Reduce Antibiotic Resistance in Pseudomonas aeruginosa.
    J Med Chem. 2023;66:15823-15846.
    >> Share

  26. LI L, Wu H, Wang J, Ji Z, et al
    Discovery of Novel 8-Hydroxyquinoline Derivatives with Potent In Vitro and In Vivo Antifungal Activity.
    J Med Chem. 2023;66:16364-16376.
    >> Share

  27. YANG Y, Zhao N, Xu X, Zhou Y, et al
    Discovery and Mechanistic Study of Novel Mycobacterium tuberculosis ClpP1P2 Inhibitors.
    J Med Chem. 2023 Dec 13. doi: 10.1021/acs.jmedchem.3c01054.
    >> Share

    November 2023
  28. CEBULA J, Fink K, Goldeman W, Szermer-Olearnik B, et al
    Structural Patterns Enhancing the Antibacterial Activity of Metallacarborane-Based Antibiotics.
    J Med Chem. 2023;66:14948-14962.
    >> Share

    October 2023
  29. KARAN S, Cho MY, Lee H, Kim HM, et al
    Hypoxia-Directed and Self-Immolative Theranostic Agent: Imaging and Treatment of Cancer and Bacterial Infections.
    J Med Chem. 2023;66:14175-14187.
    >> Share

  30. BARBACHYN MR
    Identification of a 1,2,4-Oxadiazole with Potent and Specific Activity against Clostridioides difficile, the Causative Bacterium of C. difficile Infection, an Urgent Public Health Threat.
    J Med Chem. 2023;66:13888-13890.
    >> Share

  31. WANG F, Wu J, Yuan M, Yan Z, et al
    Novel Nitric Oxide Donor-Azole Conjugation Strategy for Efficient Treatment of Cryptococcus neoformans Infections.
    J Med Chem. 2023;66:14221-14240.
    >> Share

  32. LIMWONGYUT J, Moreland AS, Zhang K, Raynor M, et al
    Amidine-Based Cationic Conjugated Oligoelectrolytes with Antimicrobial Activity against Pseudomonas aeruginosa Biofilms.
    J Med Chem. 2023;66:14303-14314.
    >> Share

  33. KIM D, Lee J, Shyaka C, Kwak JH, et al
    Identification of Micrococcin P2-Derivatives as Antibiotic Candidates against Two Gram-Positive Pathogens.
    J Med Chem. 2023;66:14263-14277.
    >> Share

  34. QIAN Y, Birhanu BT, Yang J, Ding D, et al
    A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection.
    J Med Chem. 2023;66:13891-13899.
    >> Share

  35. NANDAKUMAR M, Ollodart A, Fleck N, Kapadia NR, et al
    Dual Inhibition of Mycobacterium tuberculosis and the Host TGFBR1 by an Anilinoquinazoline.
    J Med Chem. 2023 Oct 23. doi: 10.1021/acs.jmedchem.3c01273.
    >> Share

  36. PESLALZ P, Grieshober M, Kraus F, Bleisch A, et al
    Unnatural Endotype B PPAPs as Novel Compounds with Activity against Mycobacterium tuberculosis.
    J Med Chem. 2023 Oct 12. doi: 10.1021/acs.jmedchem.3c01172.
    >> Share

  37. WANG X, Jin X, Xie Z, Zhang H, et al
    Benzamidine Conjugation Converts Expelled Potential Active Agents into Antifungals against Drug-Resistant Fungi.
    J Med Chem. 2023;66:13684-13704.
    >> Share

    September 2023
  38. YAN Z, Huang Y, Zhao D, Li Z, et al
    Developing Novel Coumarin-Containing Azoles Antifungal Agents by the Scaffold Merging Strategy for Treating Azole-Resistant Candidiasis.
    J Med Chem. 2023;66:13247-13265.
    >> Share

  39. WANG Q, Tu J, Yang W, Liang T, et al
    Discovery of Pyrazolone Carbothioamide Derivatives as Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis.
    J Med Chem. 2023;66:11893-11904.
    >> Share

  40. GOGDE K, Paul S, Pujari AK, Yadav AK, et al
    Synthesis of Metallo-Chromone Porphyrin Nano-Starch Sensitizers as Photodynamic Therapeutics for the Eradication of Enterococci Dental Pathogens.
    J Med Chem. 2023 Sep 6. doi: 10.1021/acs.jmedchem.3c01087.
    >> Share

    August 2023
  41. DEY S, Patel A, Haloi N, Srimayee S, et al
    Quinoline Thiourea-Based Zinc Ionophores with Antibacterial Activity.
    J Med Chem. 2023;66:11078-11093.
    >> Share

    July 2023
  42. SARKAR S, Mayer Bridwell AE, Good JAD, Wang ER, et al
    Design, Synthesis, and Evaluation of Novel Delta(2)-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant Mycobacterium tuberculosis Mutant.
    J Med Chem. 2023 Jul 24. doi: 10.1021/acs.jmedchem.3c00358.
    >> Share

  43. VENNARD C, Oropo T, Sintim HO
    Engineered Vancomycin, with Increased Interactions with Peptidoglycan Stem Peptide, Conquers Non-tuberculosis Mycobacteria.
    J Med Chem. 2023 Jul 21. doi: 10.1021/acs.jmedchem.3c01219.
    >> Share

    June 2023
  44. KOTEVA K, Xu M, Wang W, Fiebig-Comyn AA, et al
    Synthetic Biology Facilitates Semisynthetic Development of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus.
    J Med Chem. 2023 Jun 14. doi: 10.1021/acs.jmedchem.3c00633.
    >> Share

  45. BENDOVA K, Raclavsky V, Novotny R, Luptakova D, et al
    [(68)Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography.
    J Med Chem. 2023;66:7584-7593.
    >> Share

  46. AHIRWAR P, Kozlovskaya V, Nijampatnam B, Rojas EM, et al
    Hydrogel-Encapsulated Biofilm Inhibitors Abrogate the Cariogenic Activity of Streptococcus mutans.
    J Med Chem. 2023 Jun 7. doi: 10.1021/acs.jmedchem.3c00272.
    >> Share

    May 2023
  47. MALWAL SR, Mazurek B, Ko J, Xie P, et al
    Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in Mycobacteria.
    J Med Chem. 2023 May 26. doi: 10.1021/acs.jmedchem.3c00398.
    >> Share

  48. KONG H, Qin S, Yan D, Shen B, et al
    Development of Aromatic-Linked Diamino Acid Antimicrobial Peptide Mimics with Low Hemolytic Toxicity and Excellent Activity against Methicillin-Resistant Staphylococcus aureus (MRSA).
    J Med Chem. 2023 May 16. doi: 10.1021/acs.jmedchem.2c01583.
    >> Share

    April 2023
  49. LANG M, Ganapathy US, Mann L, Abdelaziz R, et al
    Synthesis and Characterization of Phenylalanine Amides Active against Mycobacterium abscessus and Other Mycobacteria.
    J Med Chem. 2023;66:5079-5098.
    >> Share

  50. TAN YM, Wang Y, Li S, Zhang SL, et al
    Azolylpyrimidinediols as Novel Structural Scaffolds of DNA-Groove Binders against Intractable Acinetobacter baumannii.
    J Med Chem. 2023;66:4910-4931.
    >> Share

  51. LI Z, Huang Y, Tu J, Yang W, et al
    Discovery of BRD4-HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity against Fluconazole-Resistant Candida albicans.
    J Med Chem. 2023 Apr 10. doi: 10.1021/acs.jmedchem.3c00165.
    >> Share

    March 2023
  52. DURCIK M, Cotman AE, Toplak Z, Mozina S, et al
    New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus.
    J Med Chem. 2023 Mar 6. doi: 10.1021/acs.jmedchem.2c01905.
    >> Share

    February 2023
  53. PATIL NA, Ma W, Jiang X, He X, et al
    Critical Role of Position 10 Residue in the Polymyxin Antimicrobial Activity.
    J Med Chem. 2023;66:2865-2876.
    >> Share

  54. TENG P, Shao H, Huang B, Xie J, et al
    Small Molecular Mimetics of Antimicrobial Peptides as a Promising Therapy To Combat Bacterial Resistance.
    J Med Chem. 2023;66:2211-2234.
    >> Share

  55. WANG YY, Zhang XY, Zhong XL, Huang YJ, et al
    Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones-Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa.
    J Med Chem. 2023;66:2169-2193.
    >> Share

  56. LI C, Tian X, Huang Z, Gou X, et al
    Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis.
    J Med Chem. 2023 Feb 3. doi: 10.1021/acs.jmedchem.2c01647.
    >> Share

    January 2023
  57. HUANG Y, Liu N, Pan Z, Li Z, et al
    BET-HDAC Dual Inhibitors for Combinational Treatment of Breast Cancer and Concurrent Candidiasis.
    J Med Chem. 2023;66:1239-1253.
    >> Share

  58. BHATTARAI P, Hegde P, Li W, Prathipati PK, et al
    Structural Determinants of Indole-2-carboxamides: Identification of Lead Acetamides with Pan Antimycobacterial Activity.
    J Med Chem. 2023;66:170-187.
    >> Share

    December 2022
  59. CHENG W, Xu T, Cui L, Xue Z, et al
    Discovery of Amphiphilic Xanthohumol Derivatives as Membrane-Targeting Antimicrobials against Methicillin-Resistant Staphylococcus aureus.
    J Med Chem. 2022 Dec 30. doi: 10.1021/acs.jmedchem.2c01793.
    >> Share

  60. MANDAL M, Xiao L, Pan W, Scapin G, et al
    Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates.
    J Med Chem. 2022;65:16234-16251.
    >> Share

  61. YANG R, Hou E, Cheng W, Yan X, et al
    Membrane-Targeting Neolignan-Antimicrobial Peptide Mimic Conjugates to Combat Methicillin-Resistant Staphylococcus aureus (MRSA) Infections.
    J Med Chem. 2022 Dec 13. doi: 10.1021/acs.jmedchem.2c01674.
    >> Share

    November 2022
  62. GUO X, Yan T, Rao J, An Y, et al
    Novel Feleucin-K3-Derived Peptides Modified with Sulfono-gamma-AA Building Blocks Targeting Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus Infections.
    J Med Chem. 2022 Nov 9. doi: 10.1021/acs.jmedchem.2c01396.
    >> Share

  63. SAINI V, Mehta D, Gupta S, Kumar S, et al
    Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates.
    J Med Chem. 2022 Nov 4. doi: 10.1021/acs.jmedchem.2c01293.
    >> Share

    October 2022
  64. MEIERS J, Rox K, Titz A
    Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release.
    J Med Chem. 2022;65:13988-14014.
    >> Share

  65. KUBINSKI K, Maslyk M, Janeczko M, Goldeman W, et al
    Metallacarborane Derivatives as Innovative Anti-Candida albicans Agents.
    J Med Chem. 2022 Oct 11. doi: 10.1021/acs.jmedchem.2c01167.
    >> Share

    September 2022
  66. ZHANG W, Lun S, Wang SS, Cai YP, et al
    Structure-Based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment.
    J Med Chem. 2022 Sep 29. doi: 10.1021/acs.jmedchem.2c01064.
    >> Share

  67. ANG CW, Lee BM, Jackson CJ, Wang Y, et al
    Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection.
    J Med Chem. 2022 Sep 16. doi: 10.1021/acs.jmedchem.2c00972.
    >> Share

    August 2022
  68. LI L, Wu H, Zhu S, Ji Z, et al
    Discovery of Novel 7-Hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxamide Derivatives with Potent and Selective Antifungal Activity against Cryptococcus Species.
    J Med Chem. 2022;65:11257-11269.
    >> Share

  69. HE T, Xu L, Hu Y, Tang X, et al
    Lysine-Tethered Stable Bicyclic Cationic Antimicrobial Peptide Combats Bacterial Infection in Vivo.
    J Med Chem. 2022;65:10523-10533.
    >> Share

  70. LI C, Liu S, Dong B, Li C, et al
    Discovery and Mechanistic Study of Mycobacterium tuberculosis PafA Inhibitors.
    J Med Chem. 2022 Aug 4. doi: 10.1021/acs.jmedchem.2c00289.
    >> Share

  71. ZHAO H, Gao Y, Li W, Sheng L, et al
    Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis.
    J Med Chem. 2022 Aug 1. doi: 10.1021/acs.jmedchem.2c00718.
    >> Share

    July 2022
  72. BEN HUR D, Kapach G, Wani NA, Kiper E, et al
    Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients.
    J Med Chem. 2022;65:9050-9062.
    >> Share

    June 2022
  73. BURASTERO O, Defelipe LA, Gola G, Tateosian NL, et al
    Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors.
    J Med Chem. 2022 Jun 23. doi: 10.1021/acs.jmedchem.1c02012.
    >> Share

  74. ZHANG X, Wang M, Zhu X, Peng Y, et al
    Development of Lipo-gamma-AA Peptides as Potent Antifungal Agents.
    J Med Chem. 2022;65:8029-8039.
    >> Share

    May 2022
  75. WU Y, Jiang W, Cong Z, Chen K, et al
    An Effective Strategy to Develop Potent and Selective Antifungal Agents from Cell Penetrating Peptides in Tackling Drug-Resistant Invasive Fungal Infections.
    J Med Chem. 2022;65:7296-7311.
    >> Share

  76. FERNANDES GFS, Thompson AM, Castagnolo D, Denny WA, et al
    Tuberculosis Drug Discovery: Challenges and New Horizons.
    J Med Chem. 2022 May 25. doi: 10.1021/acs.jmedchem.2c00227.
    >> Share

  77. KOKOT M, Anderluh M, Hrast M, Minovski N, et al
    The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV.
    J Med Chem. 2022;65:6431-6440.
    >> Share

  78. NACLERIO GA, Abutaleb NS, Onyedibe KI, Karanja C, et al
    Mechanistic Studies and In Vivo Efficacy of an Oxadiazole-Containing Antibiotic.
    J Med Chem. 2022;65:6612-6630.
    >> Share

  79. LI W, Yun Z, Ji C, Tu J, et al
    Discovery of Novel Sertraline Derivatives as Potent Anti-Cryptococcus Agents.
    J Med Chem. 2022;65:6541-6554.
    >> Share

    April 2022
  80. GURVIC D, Leach AG, Zachariae U
    Data-Driven Derivation of Molecular Substructures That Enhance Drug Activity in Gram-Negative Bacteria.
    J Med Chem. 2022;65:6088-6099.
    >> Share

  81. LELLA M, Oh MW, Kuo SH, Lau GW, et al
    Attenuating the Streptococcus pneumoniae Competence Regulon Using Urea-Bridged Cyclic Dominant-Negative Competence-Stimulating Peptide Analogs.
    J Med Chem. 2022 Apr 22. doi: 10.1021/acs.jmedchem.2c00148.
    >> Share

  82. YIN W, Wu T, Liu L, Jiang H, et al
    Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis.
    J Med Chem. 2022;65:5539-5564.
    >> Share

    March 2022
  83. MA Z, He S, Yuan Y, Zhuang Z, et al
    Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
    J Med Chem. 2022;65:4481-4495.
    >> Share

  84. KOBAURI P, Galenkamp NS, Schulte AM, de Vries J, et al
    Hypothesis-Driven, Structure-Based Design in Photopharmacology: The Case of eDHFR Inhibitors.
    J Med Chem. 2022;65:4798-4817.
    >> Share

    February 2022
  85. ACEBRON-GARCIA-DE-EULATE M, Mayol-Llinas J, Holland MTO, Kim SY, et al
    Discovery of Novel Inhibitors of Uridine Diphosphate-N-Acetylenolpyruvylglucosamine Reductase (MurB) from Pseudomonas aeruginosa, an Opportunistic Infectious Agent Causing Death in Cystic Fibrosis Patients.
    J Med Chem. 2022;65:2149-2173.
    >> Share

  86. MODAK B, Girkar S, Narayan R, Kapoor S, et al
    Mycobacterial Membranes as Actionable Targets for Lipid-Centric Therapy in Tuberculosis.
    J Med Chem. 2022 Feb 8. doi: 10.1021/acs.jmedchem.1c01870.
    >> Share

    January 2022
  87. OTTAVI S, Scarry SM, Mosior J, Ling Y, et al
    In Vitro and In Vivo Inhibition of the Mycobacterium tuberculosis Phosphopantetheinyl Transferase PptT by Amidinoureas.
    J Med Chem. 2022 Jan 19. doi: 10.1021/acs.jmedchem.1c01565.
    >> Share

  88. SHYAM M, Verma H, Bhattacharje G, Mukherjee P, et al
    Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition.
    J Med Chem. 2022;65:234-256.
    >> Share

  89. HU Y, Li H, Qu R, He T, et al
    Lysine Stapling Screening Provides Stable and Low Toxic Cationic Antimicrobial Peptides Combating Multidrug-Resistant Bacteria In Vitro and In Vivo.
    J Med Chem. 2022;65:579-591.
    >> Share

  90. LIU J, Hou JS, Chang YQ, Peng LJ, et al
    New Pqs Quorum Sensing System Inhibitor as an Antibacterial Synergist against Multidrug-Resistant Pseudomonas aeruginosa.
    J Med Chem. 2022;65:688-709.
    >> Share

  91. LEE D, Lee E, Jang S, Kim K, et al
    Discovery of Mycobacterium tuberculosis Rv3364c-Derived Small Molecules as Potential Therapeutic Agents to Target SNX9 for Sepsis.
    J Med Chem. 2022 Jan 4. doi: 10.1021/acs.jmedchem.1c01551.
    >> Share

    November 2021
  92. TRAN W, Kusay AS, Hawkins PME, Cheung CY, et al
    Synthetic Sansanmycin Analogues as Potent Mycobacterium tuberculosis Translocase I Inhibitors.
    J Med Chem. 2021 Nov 30. doi: 10.1021/acs.jmedchem.1c01407.
    >> Share

  93. CHOI JW, Lee KT, Kim S, Lee YR, et al
    Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.
    J Med Chem. 2021;64:15912-15935.
    >> Share

    October 2021
  94. PRATAP VERMA D, Ansari MM, Verma NK, Saroj J, et al
    Tandem Repeat of a Short Human Chemerin-Derived Peptide and Its Nontoxic d-Lysine-Containing Enantiomer Display Broad-Spectrum Antimicrobial and Antitubercular Activities.
    J Med Chem. 2021;64:15349-15366.
    >> Share

  95. FRIDIANTO KT, Li M, Hards K, Negatu DA, et al
    Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against Mycobacterium tuberculosis.
    J Med Chem. 2021 Oct 27. doi: 10.1021/acs.jmedchem.1c01383.
    >> Share

  96. CHEN Z, Song K, Shang Y, Xiong Y, et al
    Selection and Identification of Novel Antibacterial Agents against Planktonic Growth and Biofilm Formation of Enterococcus faecalis.
    J Med Chem. 2021 Oct 16. doi: 10.1021/acs.jmedchem.1c00939.
    >> Share

    August 2021
  97. PEUKERT C, Langer LNB, Wegener SM, Tutov A, et al
    Optimization of Artificial Siderophores as (68)Ga-Complexed PET Tracers for In Vivo Imaging of Bacterial Infections.
    J Med Chem. 2021;64:12359-12378.
    >> Share

  98. GOU S, Li B, Ouyang X, Ba Z, et al
    Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
    J Med Chem. 2021;64:11247-11266.
    >> Share

    July 2021
  99. KATO I, Ukai Y, Kondo N, Nozu K, et al
    Identification of Thiazoyl Guanidine Derivatives as Novel Antifungal Agents Inhibiting Ergosterol Biosynthesis for Treatment of Invasive Fungal Infections.
    J Med Chem. 2021;64:10482-10496.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016